Fischer Medical Ventures Quarterly Results for Trading Insights

In Sept 2025, Fischer Medical Ventures (FISCHER) reported revenue ₹89 Cr and net profit ₹14 Cr — revenue +122.5% YoY. For annual financials, live price and key ratios, visit FISCHER stock price BSE.

Latest Quarter Net Profit
₹14 Cr
QSept 2025
Quarterly Results

FISCHER Quarterly Results — Revenue, Profit & EPS Highlights

Fischer Medical Ventures latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with FISCHER stock valuation models to assess whether the stock is under or overvalued.

  • Revenue of ₹89 Cr in Sept 2025 (+81.6% vs Mar 2025, +122.5% vs Sept 2024)
  • Net Profit of ₹14 Cr in Sept 2025 (+1300.0% vs Mar 2025)
  • EBITDA of ₹19 Cr in Sept 2025 (+533.3% vs Mar 2025)
  • Operating Margin of 19.0% in Sept 2025 (+14.0pp vs Mar 2025)
  • Earnings Per Share of ₹0.22 in Sept 2025 (+540.0% vs Mar 2025)

Fischer Medical Ventures Quarterly Results — Revenue, EBITDA, Net Profit & EPS

FISCHER quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 89 49 31 102 40 81.6% 122.5%
Net Profit (₹ Cr) 14 1 5 19 0 - -
EBITDA (₹ Cr) 19 3 12 23 1 - -
EPS (₹) 0.22 -0.05 0.77 0.30 0.05 - -
Operating Margin (%) 19.0% 5.0% 18.0% 21.0% 1.0% - -

FISCHER Share Price Trend — 1-Year Movement Across Quarterly Results

Fischer Medical Ventures 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse FISCHER promoter holding to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 15.7%
EBITDA Margin 21.3%
Operating Margin 19.0%
ROE (Annual) 16.6%

Balance Sheet Highlights

Total Assets ₹457 Cr
Total Equity ₹338 Cr
Current Assets ₹365 Cr
Current Liabilities ₹18 Cr

Cash Flow Analysis

Operating Cash Flow ₹-87 Cr
Investing Cash Flow ₹-125 Cr
Financing Cash Flow ₹315 Cr
Net Cash Flow ₹103 Cr

Current Market Data

Current Price ₹40.13
Exchange NSE
Last Updated Apr 13, 2026

FISCHER vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Fischer Medical Ventures latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Sept 2025
₹138,121.06 Cr 1326.5 3,605 585 +11.9% - 16.2% 233.1
SRF
Sept 2025
₹73,317.72 Cr 2443.2 3,560 388 -16.2% - 10.9% 186.5
Coromandel Internat…
Sept 2025
₹61,764.26 Cr 2093.6 9,771 793 +78.9% - 8.1% 76.6
Linde
Sept 2025
₹61,319.36 Cr 7240.0 650 171 +7.4% - 26.3% 361.1
Fertilisers & Chemi…
Sept 2025
₹55,492.89 Cr 852.4 1,681 21 +48.8% - 1.2% 2663.6
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores